Concepts (190)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Quality of Life | 14 | 2023 | 521 | 2.040 |
Why?
|
| Ostomy | 11 | 2018 | 30 | 1.930 |
Why?
|
| Cancer Survivors | 7 | 2019 | 91 | 1.780 |
Why?
|
| Rectal Neoplasms | 10 | 2018 | 75 | 1.720 |
Why?
|
| Survivors | 8 | 2017 | 158 | 1.140 |
Why?
|
| Cystectomy | 2 | 2019 | 8 | 0.830 |
Why?
|
| Surveys and Questionnaires | 9 | 2019 | 1322 | 0.820 |
Why?
|
| Urinary Bladder Neoplasms | 2 | 2019 | 58 | 0.780 |
Why?
|
| Autism Spectrum Disorder | 1 | 2023 | 165 | 0.680 |
Why?
|
| Health Plan Implementation | 1 | 2019 | 36 | 0.650 |
Why?
|
| Comparative Effectiveness Research | 1 | 2019 | 66 | 0.640 |
Why?
|
| Community Health Centers | 1 | 2019 | 65 | 0.630 |
Why?
|
| Guideline Adherence | 1 | 2019 | 155 | 0.600 |
Why?
|
| Humans | 38 | 2025 | 17707 | 0.570 |
Why?
|
| Self Care | 1 | 2018 | 164 | 0.540 |
Why?
|
| Female | 29 | 2023 | 12729 | 0.540 |
Why?
|
| Colorectal Neoplasms | 4 | 2018 | 616 | 0.520 |
Why?
|
| Male | 19 | 2023 | 10094 | 0.480 |
Why?
|
| Adult | 22 | 2022 | 7658 | 0.470 |
Why?
|
| Spirituality | 1 | 2013 | 2 | 0.430 |
Why?
|
| Middle Aged | 15 | 2020 | 7976 | 0.410 |
Why?
|
| Genetic Testing | 4 | 2024 | 74 | 0.380 |
Why?
|
| Decision Making | 3 | 2019 | 182 | 0.370 |
Why?
|
| Premature Birth | 4 | 2020 | 141 | 0.370 |
Why?
|
| Minority Groups | 2 | 2023 | 101 | 0.360 |
Why?
|
| Young Adult | 9 | 2019 | 2450 | 0.340 |
Why?
|
| Gynecology | 2 | 2020 | 22 | 0.330 |
Why?
|
| Adolescent | 8 | 2023 | 3671 | 0.310 |
Why?
|
| Pregnancy | 11 | 2020 | 1535 | 0.310 |
Why?
|
| Aged | 13 | 2019 | 6150 | 0.310 |
Why?
|
| Oregon | 6 | 2020 | 187 | 0.310 |
Why?
|
| Anastomosis, Surgical | 3 | 2017 | 10 | 0.280 |
Why?
|
| Long Term Adverse Effects | 2 | 2017 | 5 | 0.280 |
Why?
|
| Adaptation, Psychological | 2 | 2013 | 79 | 0.270 |
Why?
|
| Colectomy | 2 | 2016 | 31 | 0.260 |
Why?
|
| Influenza, Human | 2 | 2020 | 267 | 0.260 |
Why?
|
| Washington | 5 | 2020 | 382 | 0.260 |
Why?
|
| Genetic Counseling | 2 | 2023 | 28 | 0.250 |
Why?
|
| Social Justice | 1 | 2025 | 6 | 0.240 |
Why?
|
| Genome, Human | 1 | 2025 | 33 | 0.240 |
Why?
|
| Body Weight | 2 | 2016 | 226 | 0.230 |
Why?
|
| Weight Gain | 2 | 2016 | 175 | 0.230 |
Why?
|
| Prospective Studies | 3 | 2023 | 1287 | 0.220 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 2023 | 6 | 0.220 |
Why?
|
| Delivery of Health Care | 2 | 2019 | 397 | 0.210 |
Why?
|
| Evidence-Based Medicine | 1 | 2024 | 179 | 0.200 |
Why?
|
| Child Health | 1 | 2023 | 35 | 0.200 |
Why?
|
| Patient Reported Outcome Measures | 2 | 2019 | 50 | 0.200 |
Why?
|
| Gestational Age | 4 | 2016 | 116 | 0.200 |
Why?
|
| Infant, Premature | 2 | 2016 | 62 | 0.200 |
Why?
|
| Research Report | 1 | 2022 | 23 | 0.190 |
Why?
|
| Quality Improvement | 1 | 2023 | 189 | 0.190 |
Why?
|
| Health Literacy | 1 | 2022 | 40 | 0.190 |
Why?
|
| Postpartum Period | 2 | 2013 | 99 | 0.190 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2020 | 147 | 0.180 |
Why?
|
| Urogenital System | 1 | 2020 | 2 | 0.170 |
Why?
|
| Vulvovaginitis | 1 | 2020 | 3 | 0.170 |
Why?
|
| Child | 3 | 2023 | 2481 | 0.170 |
Why?
|
| Urologic Diseases | 1 | 2020 | 7 | 0.170 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2000 | 9 | 0.170 |
Why?
|
| Menopause | 1 | 2020 | 70 | 0.170 |
Why?
|
| Urinary Bladder | 1 | 2019 | 10 | 0.170 |
Why?
|
| Influenza Vaccines | 2 | 2020 | 275 | 0.170 |
Why?
|
| Urinary Diversion | 1 | 2019 | 3 | 0.160 |
Why?
|
| Decision Support Techniques | 1 | 2020 | 88 | 0.160 |
Why?
|
| Infant, Newborn | 6 | 2020 | 857 | 0.160 |
Why?
|
| Child Development | 1 | 2020 | 53 | 0.160 |
Why?
|
| Self Report | 2 | 2018 | 252 | 0.160 |
Why?
|
| Socioeconomic Factors | 4 | 2013 | 626 | 0.160 |
Why?
|
| Thinness | 2 | 2016 | 32 | 0.160 |
Why?
|
| Child, Preschool | 1 | 2023 | 1417 | 0.150 |
Why?
|
| Pregnant Women | 1 | 2019 | 46 | 0.150 |
Why?
|
| Postoperative Complications | 2 | 2017 | 103 | 0.150 |
Why?
|
| Patient Selection | 1 | 2019 | 190 | 0.140 |
Why?
|
| Prenatal Care | 1 | 2019 | 129 | 0.140 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2020 | 324 | 0.140 |
Why?
|
| California | 3 | 2019 | 2327 | 0.140 |
Why?
|
| Activities of Daily Living | 1 | 2018 | 85 | 0.140 |
Why?
|
| Employment | 1 | 2018 | 44 | 0.140 |
Why?
|
| Aged, 80 and over | 3 | 2018 | 1927 | 0.140 |
Why?
|
| Primary Health Care | 2 | 2020 | 756 | 0.140 |
Why?
|
| Research Design | 1 | 2019 | 372 | 0.140 |
Why?
|
| Parents | 1 | 2000 | 295 | 0.140 |
Why?
|
| Population Surveillance | 1 | 2019 | 265 | 0.140 |
Why?
|
| Social Participation | 1 | 2017 | 3 | 0.140 |
Why?
|
| Defecation | 1 | 2017 | 6 | 0.140 |
Why?
|
| Rectum | 1 | 2017 | 13 | 0.140 |
Why?
|
| Blood Glucose | 1 | 2019 | 348 | 0.140 |
Why?
|
| Fetal Membranes, Premature Rupture | 1 | 2016 | 12 | 0.130 |
Why?
|
| Ethnic Groups | 1 | 2019 | 474 | 0.130 |
Why?
|
| Recreation | 1 | 2017 | 38 | 0.130 |
Why?
|
| Organ Sparing Treatments | 1 | 2016 | 3 | 0.130 |
Why?
|
| Health Services | 2 | 2019 | 114 | 0.130 |
Why?
|
| Infant, Postmature | 1 | 2015 | 1 | 0.130 |
Why?
|
| Birth Certificates | 1 | 2015 | 24 | 0.120 |
Why?
|
| Health Status | 2 | 2018 | 299 | 0.120 |
Why?
|
| Gastrointestinal Diseases | 1 | 2015 | 27 | 0.120 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2019 | 387 | 0.120 |
Why?
|
| Sexual Behavior | 1 | 2016 | 123 | 0.120 |
Why?
|
| Medical Records | 1 | 2015 | 97 | 0.120 |
Why?
|
| Body Mass Index | 3 | 2016 | 970 | 0.120 |
Why?
|
| Vaccination | 1 | 2019 | 656 | 0.110 |
Why?
|
| Pregnancy Complications | 2 | 2016 | 203 | 0.110 |
Why?
|
| Mass Screening | 1 | 2019 | 667 | 0.110 |
Why?
|
| Fetal Macrosomia | 1 | 2013 | 27 | 0.110 |
Why?
|
| Sickness Impact Profile | 1 | 2013 | 26 | 0.110 |
Why?
|
| Pregnancy Outcome | 4 | 2016 | 162 | 0.110 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2013 | 58 | 0.100 |
Why?
|
| Infant Care | 1 | 2013 | 7 | 0.100 |
Why?
|
| Diet | 1 | 2015 | 367 | 0.100 |
Why?
|
| Diabetes, Gestational | 2 | 2019 | 348 | 0.100 |
Why?
|
| Maternal Death | 1 | 2012 | 2 | 0.100 |
Why?
|
| Depression, Postpartum | 1 | 2013 | 20 | 0.100 |
Why?
|
| Exercise | 1 | 2017 | 496 | 0.100 |
Why?
|
| Interviews as Topic | 1 | 2013 | 301 | 0.100 |
Why?
|
| Child Health Services | 1 | 2013 | 106 | 0.100 |
Why?
|
| Term Birth | 1 | 2012 | 9 | 0.100 |
Why?
|
| Anxiety Disorders | 1 | 2013 | 90 | 0.100 |
Why?
|
| Cross-Sectional Studies | 4 | 2017 | 1322 | 0.100 |
Why?
|
| Qualitative Research | 1 | 2013 | 257 | 0.100 |
Why?
|
| Anxiety | 1 | 2013 | 152 | 0.090 |
Why?
|
| Social Support | 1 | 2013 | 204 | 0.090 |
Why?
|
| Prognosis | 3 | 2019 | 613 | 0.090 |
Why?
|
| Longitudinal Studies | 3 | 2019 | 717 | 0.090 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2011 | 25 | 0.090 |
Why?
|
| Receptor, ErbB-2 | 1 | 2011 | 47 | 0.090 |
Why?
|
| Infant | 4 | 2020 | 1199 | 0.090 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2011 | 41 | 0.090 |
Why?
|
| Depression | 1 | 2015 | 504 | 0.090 |
Why?
|
| Risk Factors | 4 | 2023 | 3367 | 0.090 |
Why?
|
| Health Maintenance Organizations | 1 | 2012 | 414 | 0.090 |
Why?
|
| Cohort Studies | 4 | 2019 | 2589 | 0.080 |
Why?
|
| Follow-Up Studies | 3 | 2017 | 1218 | 0.070 |
Why?
|
| Length of Stay | 3 | 2013 | 182 | 0.070 |
Why?
|
| Anal Canal | 2 | 2017 | 9 | 0.070 |
Why?
|
| United States | 3 | 2025 | 3914 | 0.070 |
Why?
|
| Retrospective Studies | 3 | 2019 | 2471 | 0.070 |
Why?
|
| Glucose Tolerance Test | 2 | 2019 | 113 | 0.060 |
Why?
|
| Patient Preference | 2 | 2016 | 48 | 0.060 |
Why?
|
| Neoplasm Invasiveness | 2 | 2019 | 80 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2012 | 755 | 0.060 |
Why?
|
| Whole Genome Sequencing | 1 | 2024 | 8 | 0.060 |
Why?
|
| Incidental Findings | 1 | 2024 | 27 | 0.060 |
Why?
|
| Infant, Newborn, Diseases | 2 | 2015 | 36 | 0.050 |
Why?
|
| Breast Neoplasms | 1 | 2011 | 956 | 0.050 |
Why?
|
| Logistic Models | 2 | 2018 | 918 | 0.050 |
Why?
|
| Delivery, Obstetric | 2 | 2013 | 19 | 0.050 |
Why?
|
| Chromosome Mapping | 1 | 2022 | 18 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2023 | 377 | 0.050 |
Why?
|
| Data Collection | 1 | 2022 | 252 | 0.050 |
Why?
|
| Communication | 1 | 2022 | 191 | 0.040 |
Why?
|
| Syndrome | 1 | 2020 | 29 | 0.040 |
Why?
|
| Vaccines, Inactivated | 1 | 2020 | 68 | 0.040 |
Why?
|
| Atrophy | 1 | 2019 | 6 | 0.040 |
Why?
|
| Attitude | 1 | 2019 | 30 | 0.040 |
Why?
|
| Prenatal Diagnosis | 1 | 2019 | 18 | 0.040 |
Why?
|
| Glucose Intolerance | 1 | 2019 | 46 | 0.040 |
Why?
|
| Family Characteristics | 1 | 2019 | 56 | 0.040 |
Why?
|
| Patient Satisfaction | 1 | 2019 | 204 | 0.040 |
Why?
|
| Volunteers | 1 | 2018 | 13 | 0.040 |
Why?
|
| Survivorship | 1 | 2018 | 10 | 0.040 |
Why?
|
| Hispanic Americans | 1 | 2019 | 397 | 0.030 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2016 | 18 | 0.030 |
Why?
|
| European Continental Ancestry Group | 1 | 2019 | 523 | 0.030 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2016 | 26 | 0.030 |
Why?
|
| Sexual Partners | 1 | 2016 | 38 | 0.030 |
Why?
|
| Health Surveys | 1 | 2016 | 260 | 0.030 |
Why?
|
| Cost of Illness | 1 | 2015 | 94 | 0.030 |
Why?
|
| Focus Groups | 1 | 2015 | 146 | 0.030 |
Why?
|
| Survival Rate | 1 | 2015 | 262 | 0.030 |
Why?
|
| Disease Management | 1 | 2015 | 136 | 0.030 |
Why?
|
| Factor Analysis, Statistical | 1 | 2014 | 36 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 331 | 0.030 |
Why?
|
| Psychometrics | 1 | 2014 | 122 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 371 | 0.030 |
Why?
|
| Health Services Accessibility | 1 | 2015 | 280 | 0.030 |
Why?
|
| Georgia | 1 | 2012 | 27 | 0.030 |
Why?
|
| Morbidity | 1 | 2012 | 59 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2013 | 296 | 0.020 |
Why?
|
| Medicaid | 1 | 2013 | 188 | 0.020 |
Why?
|
| Cesarean Section | 1 | 2012 | 33 | 0.020 |
Why?
|
| Trastuzumab | 1 | 2011 | 15 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2011 | 21 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2011 | 15 | 0.020 |
Why?
|
| SEER Program | 1 | 2011 | 92 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2011 | 60 | 0.020 |
Why?
|
| Continental Population Groups | 1 | 2012 | 301 | 0.020 |
Why?
|
| Time Factors | 1 | 2013 | 1095 | 0.020 |
Why?
|
| Patient Readmission | 1 | 2012 | 164 | 0.020 |
Why?
|
| Emergency Service, Hospital | 1 | 2012 | 377 | 0.020 |
Why?
|
Concepts
(190)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(21)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_
-->